Olivia Campbell

Associate

Olivia Campbell represents a variety of clients in Choate’s Litigation Department. She assists clients in the pharmaceutical and technology industries in complex litigation and intellectual property matters, including government enforcement actions and patent litigation. Additionally, Olivia has worked with companies in the insurance and reinsurance industries, advising in complex coverage disputes and preparing for arbitration.

While in law school, Olivia was a legal intern at the Massachusetts Office of the Attorney General in the White Collar and Public Integrity Division. She was also a student attorney at the BU/MIT Technology Law Clinic.

Representative Engagements

  • Assist in representing software technology company in patent infringement and trade secret litigation relating to systems for de-identifying data.
  • Advise global insurer in complex reinsurance coverage dispute concerning nationwide abuse claims.
  • Assist in representing global pharmaceutical company in federal False Claims Act investigation.
  • Represent Sir Paul Winter and Interested Scientists in filing amicus brief in the Supreme Court case Amgen Inc., et al. v. Sanofi, et. al.

Education & Credentials

Boston University School of Law
JD, 2022, cum laude
Editor, Journal of Science and Technology Law
Harvard University
BA, 2017, cum laude

Admissions

Massachusetts

U.S. District Court, Massachusetts

Olivia 's Insights

Announcements 04.03.2023

National Attention for Choate’s U.S. Supreme Court Amicus Brief in Amgen v. Sanofi et al.

On March 27, the U.S. Supreme Court heard arguments in Amgen v. Sanofi et al, No. 21-757, one of this term’s most highly-watched cases concerning the law of enablement as it applies to patents directed to antibody therapeutics. Choate’s amicus brief, submitted on behalf of Nobel Prize laureate Sir Gregory Paul Winter and other interested scientists in support of Sanofi and Regeneron, was repeatedly highlighted by counsel during the argument. 

Announcements 02.15.2023

Choate Submits Amicus Brief to the US Supreme Court on behalf of Nobel Laureate Sir Gregory Paul Winter and Interested Scientists in Amgen v. Sanofi et al.

On February 10, 2023, Choate submitted an amicus brief to the U.S. Supreme Court on behalf of Sir Gregory Paul Winter and other interested scientists in support of Sanofi and Regeneron in Amgen v. Sanofi et al, No. 21-757.  The case involves the law of enablement for patents and whether the Federal Circuit Court of Appeals correctly interpreted the law when it invalidated Amgen’s patents directed to broad classes of antibody drugs called PCSK9 inhibitors.